| Analysis | Metabolite Name | Measured Value | Units | Treament | Exposure |
|---|---|---|---|---|---|
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 630093312 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 646844672 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 648916608 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 740465920 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 798057152 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 879042304 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 912457536 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 930902208 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 933528128 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 972024896 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 996472704 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1003609792 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1024246144 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1078453248 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1115137664 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1130100736 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1250255360 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1300041216 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1300512256 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1324830720 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1445899776 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1528214144 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1615838976 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1704898816 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1743011584 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1745721472 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1792564736 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1836603520 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1856654336 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1966403840 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 2047937536 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 2199435520 | Area under curve | Antibiotics | Ozone |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|